Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXGK7O
|
||||
Drug Name |
4-(5-{[2-(3-Chloro-benzyl)-3-oxo-2,3,4,5-tetrahydro-1H-benzo[c]azepin-4-ylamino]-methyl}-imidazol-1-ylmethyl)-benzonitrile
|
||||
Synonyms |
CHEMBL351004
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C29H26ClN5O
|
||||
Canonical SMILES |
Clc1cccc(CN2Cc3ccccc3CC(NCc4cncn4Cc5ccc(cc5)C#N)C2=O)c1
|
||||
InChI |
InChI=1S/C29H26ClN5O/c30-26-7-3-4-23(12-26)18-34-19-25-6-2-1-5-24(25)13-28(29(34)36)33-16-27-15-32-20-35(27)17-22-10-8-21(14-31)9-11-22/h1-12,15,20,28,33H,13,16-19H2
|
||||
InChIKey |
WDYGFNPGSTZSNU-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.